The Inhibitory Effect of Eupatilin on the Agonist-Induced Regulation of Vascular Contractility.
10.4196/kjpp.2013.17.1.31
- Author:
Hyun Dong JE
1
;
Hyeong Dong KIM
;
Ji Hoon JEONG
Author Information
1. Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongbuk 712-702, Korea.
- Publication Type:Original Article
- Keywords:
ERK1/2;
Eupatilin;
MYPT1;
Rho-kinase;
Vasodilation
- MeSH:
Animals;
Contracts;
Flavonoids;
Hand;
Humans;
Isometric Contraction;
Male;
Muscle, Smooth, Vascular;
Nitric Oxide;
Phorbols;
Phosphorylation;
Rats;
Relaxation;
rho-Associated Kinases;
Thromboxane A2;
Vasodilation
- From:The Korean Journal of Physiology and Pharmacology
2013;17(1):31-36
- CountryRepublic of Korea
- Language:English
-
Abstract:
The present study was undertaken to investigate the influence of eupatilin on vascular smooth muscle contractility and to determine the mechanism involved. Denuded aortic rings from male rats were used and isometric contractions were recorded and combined with molecular experiments. Eupatilin more significantly relaxed fluoride-induced vascular contraction than thromboxane A2 or phorbol ester-induced contraction suggesting as a possible anti-hypertensive on the agonist-induced vascular contraction regardless of endothelial nitric oxide synthesis. Furthermore, eupatilin significantly inhibited fluoride-induced increases in pMYPT1 levels. On the other hand, it didn't significantly inhibit phorbol ester-induced increases in pERK1/2 levels suggesting the mechanism involving the primarily inhibition of Rho-kinase activity and the subsequent phosphorylation of MYPT1. This study provides evidence regarding the mechanism underlying the relaxation effect of eupatilin on agonist-induced vascular contraction regardless of endothelial function.
